摘要
尽管强大的新技术已经确定了许多新的人类和动物病毒,之前未知的病毒,如中东呼吸综合征冠状病毒不断涌现并威胁人类健康。同样的,现有的病毒如从埃博拉到基孔肯雅病毒,再度出现并传播到新的地理区域。由于其高致病性的研究,对这些病毒的研究往往是一项极具挑战的工作。慢病毒载体和假病毒是研究包膜病毒的良好工具,其促进了受体使用、病毒进入和血清学的研究进展。特别是,假病毒允许未知的或高致病性病毒的安全研究。他们还允许初始的感染特性如难培养病毒的细胞嗜性。本文将介绍了各种新兴病毒如基孔肯雅病毒、埃博拉病毒、SARS和MERS冠状病毒和尼帕病毒的假型系统,以及他们在不同的研究如药物筛选和抗体中和中的应用。我们同时也讨论了使用假病毒的限制和潜在的注意事项。
关键词: 假病毒,慢病毒载体,rhabdoviral载体,新型病毒,包膜病毒,血清学,药物筛选。
Current Gene Therapy
Title:Pseudotyping Viral Vectors With Emerging Virus Envelope Proteins
Volume: 16 Issue: 1
Author(s): Imke Steffen and Graham Simmons
Affiliation:
关键词: 假病毒,慢病毒载体,rhabdoviral载体,新型病毒,包膜病毒,血清学,药物筛选。
摘要: Previously unidentified viruses, such as Middle East respiratory syndrome coronavirus, continue to emerge and threaten populations, while powerful new techniques have identified many new human and animal viruses. Similarly, existing viruses, from Ebola virus to chikungunya virus, are reemerging and spreading to new geographical regions. These viruses often pose a challenge for researchers to study due to their highly pathogenic nature. Lentiviral and rhabdoviral pseudotypes are excellent tools for studying enveloped viruses and have contributed to many recent advances in areas such as receptor usage, viral entry and serology. In particular, pseudotypes allow the safe study of unknown or highly pathogenic viruses. They also allow the initial characterization of aspects of infection such as cellular tropism for difficult to culture viruses. In this review we will introduce various pseudotyping systems for emerging viruses, including chikungunya virus, Ebola virus, SARS and MERS coronaviruses and Nipah virus, as well as their use in diverse studies including drug screening and antibody neutralization. We will also discuss the limitations and potential caveats using pseudotypes.
Export Options
About this article
Cite this article as:
Imke Steffen and Graham Simmons , Pseudotyping Viral Vectors With Emerging Virus Envelope Proteins, Current Gene Therapy 2016; 16 (1) . https://dx.doi.org/10.2174/1566523216666160119093948
DOI https://dx.doi.org/10.2174/1566523216666160119093948 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Design, Synthesis and Biological Evaluation of Antipicornaviral Pyrrole-Containing Peptidomimetics
Protein & Peptide Letters Can the Written Word Fuel Pharmaceutical Innovation? Part 1. An Emerging Vista from von Economo to COVID-19
Combinatorial Chemistry & High Throughput Screening The Effect of Pharmacotherapy for Attention Deficit Hyperactivity Disorder on Risk of Seizures in Pediatric Patients as Assessed in an Insurance Claims Database
Current Drug Safety Beyond Oncolytic Virotherapy: Replication-Competent Retrovirus Vectors for Selective and Stable Transduction of Tumors
Current Gene Therapy Antibodies Against Refolded Recombinant Envelope Protein (Domain III) of Japanese Encephalitis Virus Inhibit the JEV Infection to Porcine Stable Kidney Cells
Protein & Peptide Letters Medicinal Plants with anti-Acanthamoeba Activity: A Systematic Review
Infectious Disorders - Drug Targets Silybin and Silymarin - New and Emerging Applications in Medicine
Current Medicinal Chemistry Combinatorial Approaches to Iminosugars as Glycosidase and Glycosyltransferase Inhibitors
Combinatorial Chemistry & High Throughput Screening Stairway to Heaven or Hell? Perspectives and Limitations of Chagas Disease Chemotherapy
Current Topics in Medicinal Chemistry Tetracyclines and Pulmonary Inflammation
Endocrine, Metabolic & Immune Disorders - Drug Targets Pharmacological Modulation of Th17
Recent Patents on Inflammation & Allergy Drug Discovery The Peripheral Benzodiazepine Receptor: A Promising Therapeutic Drug Target
Current Medicinal Chemistry Virulence on the Fly: Drosophila melanogaster as a Model Genetic Organism to Decipher Host-Pathogen Interactions
Current Drug Targets Biological Relevance of Lysophospholipids and Green Solutions for Their Synthesis
Current Organic Chemistry Recent Achievements in Understanding Immune Recovery of Children Treated with HAART
Current Pediatric Reviews Biological Drugs in Guillain-Barré Syndrome: An Update
Current Neuropharmacology Understanding Effects of Psychological Stress on Physiology and Disease Through Human Stressome - An Integral Algorithm
Current Bioinformatics α-Galactosylceramide: Potential Immunomodulatory Activity and Future Application [General Articles]
Current Medicinal Chemistry Inflammation-Mediating Proteases: Structure, Function in (Patho) Physiology and Inhibition
Protein & Peptide Letters Tau-Focused Immunotherapy for Alzheimers Disease and Related Tauopathies
Current Alzheimer Research